Thomas M, Al Kashroom H, Reddy S, Zaccarini D, Willer K
J Clin Med Res. 2024; 16(5):197-207.
PMID: 38855781
PMC: 11161189.
DOI: 10.14740/jocmr5169.
Ahmad H, Ali A, Khalil A, Ali R, Khan I, Khan M
Front Genet. 2024; 15:1383284.
PMID: 38784039
PMC: 11111998.
DOI: 10.3389/fgene.2024.1383284.
Valentini V, Bucalo A, Conti G, Celli L, Porzio V, Capalbo C
Cancers (Basel). 2024; 16(3).
PMID: 38339330
PMC: 10854694.
DOI: 10.3390/cancers16030579.
Giacobbe G, Granata V, Trovato P, Fusco R, Simonetti I, De Muzio F
J Pers Med. 2023; 13(2).
PMID: 36836457
PMC: 9966684.
DOI: 10.3390/jpm13020223.
Pensabene M, von Arx C, De Laurentiis M
Cancers (Basel). 2022; 14(8).
PMID: 35454911
PMC: 9030724.
DOI: 10.3390/cancers14082006.
Genetic predisposition to male breast cancer in Poland.
Szwiec M, Tomiczek-Szwiec J, Kluzniak W, Wokolorczyk D, Osowiecka K, Sibilski R
BMC Cancer. 2021; 21(1):975.
PMID: 34461861
PMC: 8406897.
DOI: 10.1186/s12885-021-08718-3.
Genetic Landscape of Male Breast Cancer.
Campos F, Rouleau E, Torrezan G, Carraro D, Rocha J, Mantovani H
Cancers (Basel). 2021; 13(14).
PMID: 34298749
PMC: 8305894.
DOI: 10.3390/cancers13143535.
Family history of breast cancer in men with non-BRCA male breast cancer: implications for cancer risk counseling.
Calip G, Kidd J, Bernhisel R, Cox H, Saam J, Rauscher G
Breast Cancer Res Treat. 2020; 185(1):195-204.
PMID: 32918117
PMC: 7855353.
DOI: 10.1007/s10549-020-05922-w.
Male Breast Cancer: Results of the Application of Multigene Panel Testing to an Italian Cohort of Patients.
Tedaldi G, Tebaldi M, Zampiga V, Cangini I, Pirini F, Ferracci E
Diagnostics (Basel). 2020; 10(5).
PMID: 32365798
PMC: 7277207.
DOI: 10.3390/diagnostics10050269.
Male Breast Cancer: Current Trends-a Tertiary Care Centre Experience.
Shah T, Shah N, Vijay D, Patel B, Patel S
Indian J Surg Oncol. 2020; 11(1):7-11.
PMID: 32205960
PMC: 7064676.
DOI: 10.1007/s13193-019-01021-5.
Male patient with metastatic stage IV breast cancer achieves complete remission on second line Abemaciclib, Fulvestrant and Leuprolide: A case report.
Hansra D, Jackson S, Sequeira J, Vazirani R, Alvarez R
Mol Clin Oncol. 2020; 12(2):120-125.
PMID: 31929882
PMC: 6951239.
DOI: 10.3892/mco.2019.1955.
Prevalence of PALB2 Germline Mutations in Early-onset and Familial Breast/Ovarian Cancer Patients from Pakistan.
Rashid M, Khan F, Muhammad N, Loya A, Hamann U
Cancer Res Treat. 2018; 51(3):992-1000.
PMID: 30309218
PMC: 6639217.
DOI: 10.4143/crt.2018.356.
Male breast cancer: a disease distinct from female breast cancer.
Gucalp A, Traina T, Eisner J, Parker J, Selitsky S, Park B
Breast Cancer Res Treat. 2018; 173(1):37-48.
PMID: 30267249
PMC: 7513797.
DOI: 10.1007/s10549-018-4921-9.
PALB2 mutations in BRCA1/2-mutation negative breast and ovarian cancer patients from Poland.
Kluska A, Balabas A, Piatkowska M, Czarny K, Paczkowska K, Nowakowska D
BMC Med Genomics. 2017; 10(1):14.
PMID: 28279176
PMC: 5345197.
DOI: 10.1186/s12920-017-0251-8.
Development of a novel PTT assay for mutation detection in PALB2 large exons and PALB2 screening in medullary breast cancer.
Poumpouridou N, Goutas N, Tsionou C, Dimas K, Lianidou E, Kroupis C
Fam Cancer. 2015; 15(2):183-91.
PMID: 26573693
DOI: 10.1007/s10689-015-9851-7.
Systematic evaluation of underlying defects in DNA repair as an approach to case-only assessment of familial prostate cancer.
Nicolas E, Arora S, Zhou Y, Serebriiskii I, Andrake M, Handorf E
Oncotarget. 2015; 6(37):39614-33.
PMID: 26485759
PMC: 4741850.
DOI: 10.18632/oncotarget.5554.
Analysis of PALB2 in a cohort of Italian breast cancer patients: identification of a novel PALB2 truncating mutation.
Vietri M, Caliendo G, Schiano C, Casamassimi A, Molinari A, Napoli C
Fam Cancer. 2015; 14(3):341-8.
PMID: 25666743
DOI: 10.1007/s10689-015-9786-z.
Inherited and acquired alterations in development of breast cancer.
Rizzolo P, Silvestri V, Falchetti M, Ottini L
Appl Clin Genet. 2013; 4:145-58.
PMID: 23776375
PMC: 3681186.
DOI: 10.2147/TACG.S13226.
Germline mutations in BRIP1 and PALB2 in Jewish high cancer risk families.
Catucci I, Milgrom R, Kushnir A, Laitman Y, Paluch-Shimon S, Volorio S
Fam Cancer. 2012; 11(3):483-91.
PMID: 22692731
DOI: 10.1007/s10689-012-9540-8.
Gene copy number variation in male breast cancer by aCGH.
Tommasi S, Mangia A, Iannelli G, Chiarappa P, Rossi E, Ottini L
Cell Oncol (Dordr). 2011; 34(5):467-73.
PMID: 21547577
DOI: 10.1007/s13402-011-0041-9.
